Objective: To understand better the public perception and comprehension of medical technology such as artificial intelligence (AI) and robotic surgery. In addition to this, to identify sensitivity to their use to ensure acceptability and quality of counseling. Subjects and Methods: A survey was conducted on a convenience sample of visitors to the MN Minnesota State Fair ( n = 264). Participants were randomized to receive one of two similar surveys. In the first, a diagnosis was made by a physician and in the second by an AI application to compare confidence in human and computer-based diagnosis. Results: The median age of participants was 45 (interquartile range 28–59), 58% were female ( n = 154) vs 42% male ( n = 110), 69% had completed at least a bachelor's degree, 88% were Caucasian ( n = 233) vs 12% ethnic minorities ( n = 31) and were from 12 states, mostly from the Upper Midwest. Participants had nearly equal trust in AI vs physician diagnoses. However, they were significantly more likely to trust an AI diagnosis of cancer over a doctor's diagnosis when responding to the version of the survey that suggested that an AI could make medical diagnoses ( p = 9.32e-06). Though 55% of respondents ( n = 145) reported that they were uncomfortable with automated robotic surgery, the majority of the individuals surveyed (88%) mistakenly believed that partially autonomous surgery was already happening. Almost all (94%, n = 249) stated that they would be willing to pay for a review of medical imaging by an AI if available. Conclusion: Most participants express confidence in AI providing medical diagnoses, sometimes even over human physicians. Participants generally express concern with surgical AI, but they mistakenly believe that it is already being performed. As AI applications increase in medical practice, health care providers should be cognizant of the potential amount of misinformation and sensitivity that patients have to how such technology is represented.
Purpose:To automate R.E.N.A.L. nephrometry scoring of preoperative computed tomography (CT) scans and create an artificial intelligence generated score (AI-Score). Subsequently, to evaluate its abi...
Artificial intelligence (AI) is rapidly transforming healthcare, but its benefits are not reaching all patients equally. Children remain overlooked with only 17% of FDA-approved medical AI devices labeled for pediatric use. In this work, we demonstrate that this exclusion may stem from a fundamental data gap. Our systematic review of 181 public medical imaging datasets reveals that children represent just under 1% of available data, while the majority of machine learning imaging conference papers we surveyed utilized publicly available data for methods development. Much like systematic biases of other kinds in model development, past studies have demonstrated the manner in which pediatric representation in data used for models intended for the pediatric population is essential for model performance in that population. We add to these findings, showing that adult-trained chest radiograph models exhibit significant age bias when applied to pediatric populations, with higher false positive rates in younger children. This work underscores the urgent need for increased pediatric representation in publicly accessible medical datasets. We provide actionable recommendations for researchers, policymakers, and data curators to address this age equity gap and ensure AI benefits patients of all ages. 1-2 sentence summary Our analysis reveals a critical healthcare age disparity: children represent less than 1% of public medical imaging datasets. This gap in representation leads to biased predictions across medical image foundation models, with the youngest patients facing the highest risk of misdiagnosis.
Purpose: Clinicians rely on imaging features to calculate complexity of renal masses based on validated scoring systems. These scoring methods are labor-intensive and are subjected to interobserver variability. Artificial intelligence has been increasingly utilized by the medical community to solve such issues. However, developing reliable algorithms is usually time-consuming and costly. We created an international community-driven competition (KiTS19) to develop and identify the best system for automatic segmentation of kidneys and kidney tumors in contrast CT and report the results.Methods: A training and test set of CT scans that was manually annotated by trained individuals were generated from consecutive patients undergoing renal surgery for whom demographic, clinical and outcome data were available. The KiTS19 Challenge was a machine learning competition hosted on grand-challenge.org in conjunction with an international conference. Teams were given 3 months to develop their algorithm using a full-annotated training set of images and an unannotated test set was released for 2 weeks from which average Sørensen-Dice coefficient between kidney and tumor regions were calculated across all 90 test cases.Results: There were 100 valid submissions that were based on deep neural networks but there were differences in pre-processing strategies, architectural details, and training procedures. The winning team scored a 0.974 kidney Dice and a 0.851 tumor Dice resulting in 0.912 composite score. Automatic segmentation of the kidney by the participating teams performed comparably to expert manual segmentation but was less reliable when segmenting the tumor.Conclusion: Rapid advancement in automated semantic segmentation of kidney lesions is possible with relatively high accuracy when the data is released publicly, and participation is incentivized. We hope that our findings will encourage further research that would enable the potential of adopting AI into the medical field.